Published in AIDS Patient Care STDS on May 01, 2013
Retention in care is more strongly associated with viral suppression in HIV-infected patients with lower versus higher CD4 counts. J Acquir Immune Defic Syndr (2014) 1.19
Health insurance coverage for persons in HIV care, 2006-2012. J Acquir Immune Defic Syndr (2014) 1.05
Aging and loss to follow-up among youth living with human immunodeficiency virus in the HIV Research Network. J Adolesc Health (2015) 0.93
Assessing the overall quality of health care in persons living with HIV in an urban environment. AIDS Patient Care STDS (2014) 0.81
Hepatitis C virus testing in adults living with HIV: a need for improved screening efforts. PLoS One (2014) 0.79
The Impact of Youth-Friendly Structures of Care on Retention Among HIV-Infected Youth. AIDS Patient Care STDS (2016) 0.79
Towards an integrated framework for accelerating the end for the global HIV epidemic among young people. Sex Educ (2014) 0.77
Comparison of HIV outcomes for patients linked at hospital versus community-based clinics. AIDS Patient Care STDS (2015) 0.75
Caring for Lesbian, Gay, Bisexual, Transgender, and Questioning Youth in Inclusive and Affirmative Environments. Pediatr Clin North Am (2016) 0.75
The quality of health care delivered to adults in the United States. N Engl J Med (2003) 50.33
Estimated HIV incidence in the United States, 2006-2009. PLoS One (2011) 13.03
Retention in care: a challenge to survival with HIV infection. Clin Infect Dis (2007) 10.66
Is there time for management of patients with chronic diseases in primary care? Ann Fam Med (2005) 10.12
Advanced access: reducing waiting and delays in primary care. JAMA (2003) 7.15
The Group Health medical home at year two: cost savings, higher patient satisfaction, and less burnout for providers. Health Aff (Millwood) (2010) 6.60
A house is not a home: keeping patients at the center of practice redesign. Health Aff (Millwood) (2008) 5.28
Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions. Ann Intern Med (1999) 5.05
Missed visits and mortality among patients establishing initial outpatient HIV treatment. Clin Infect Dis (2009) 4.96
The effect of electronic prescribing on medication errors and adverse drug events: a systematic review. J Am Med Inform Assoc (2008) 4.77
Geriatric care management for low-income seniors: a randomized controlled trial. JAMA (2007) 4.32
The therapeutic implications of timely linkage and early retention in HIV care. AIDS Patient Care STDS (2009) 3.78
Association between adherence to antiretroviral therapy and human immunodeficiency virus drug resistance. Clin Infect Dis (2003) 3.63
Effect of clinical decision-support systems: a systematic review. Ann Intern Med (2012) 3.42
HIV System Navigation: an emerging model to improve HIV care access. AIDS Patient Care STDS (2007) 3.02
HIV transmission risk behaviors among HIV-infected persons who are successfully linked to care. Clin Infect Dis (2008) 2.44
Nonadherence to medical appointments is associated with increased plasma HIV RNA and decreased CD4 cell counts in a community-based HIV primary care clinic. AIDS Care (2005) 2.42
Growing up with HIV: children, adolescents, and young adults with perinatally acquired HIV infection. Annu Rev Med (2010) 2.28
Improving adherence to antiretroviral therapy for youth living with HIV/AIDS: a pilot study using personalized, interactive, daily text message reminders. J Med Internet Res (2012) 2.15
Advanced access scheduling outcomes: a systematic review. Arch Intern Med (2011) 2.06
Improving engagement in HIV care: what can we do? Top HIV Med (2008) 2.05
Comparing different measures of retention in outpatient HIV care. AIDS (2012) 1.98
Structures of care in the clinics of the HIV Research Network. AIDS Patient Care STDS (2008) 1.69
Open access in primary care: results of a North Carolina pilot project. Pediatrics (2005) 1.62
Linkage and retention in HIV care among men who have sex with men in the United States. Clin Infect Dis (2011) 1.59
The effect of technology-supported, multidisease care management on the mortality and hospitalization of seniors. J Am Geriatr Soc (2008) 1.52
Vulnerability, risk, and protection. J Adolesc Health (2002) 1.52
Association of ancillary services with primary care utilization and retention for patients with HIV/AIDS. AIDS Care (2002) 1.49
Effect of improved primary care access on quality of depression care. Ann Fam Med (2006) 1.45
The impact of ancillary HIV services on engagement in medical care in New York City. AIDS Care (2002) 1.43
Understanding the behavioral determinants of retention in HIV care: a qualitative evaluation of a situated information, motivation, behavioral skills model of care initiation and maintenance. AIDS Patient Care STDS (2012) 1.34
Patterns of ambulatory care for AIDS patients, and association with emergency room use. Health Serv Res (1994) 1.26
Repeated emergency department use by HIV-infected persons: effect of clinic accessibility and expertise in HIV care. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 1.21
Treating depression within the HIV "medical home": a guided algorithm for antidepressant management by HIV clinicians. AIDS Patient Care STDS (2012) 1.18
Barriers to health care for street youth. J Adolesc Health (1997) 1.14
Technology use and reasons to participate in social networking health websites among people living with HIV in the US. AIDS Behav (2012) 1.07
Development and pilot testing of a standardized training program for a patient-mentoring intervention to increase adherence to outpatient HIV care. AIDS Patient Care STDS (2012) 1.03
Patients in transition: avoiding detours on the road to HIV treatment success. AIDS (2013) 0.98
Adherence to scheduled appointments among HIV-infected female youth in five U.S. cities. J Adolesc Health (2009) 0.97
Ancillary services and retention of youth in HIV care. AIDS Care (2007) 0.93
Timed short messaging service improves adherence and virological outcomes in HIV-1-infected patients with suboptimal adherence to antiretroviral therapy. J Acquir Immune Defic Syndr (2011) 0.93
Brief report: Predictors of optimal HIV appointment adherence in minority youth: a prospective study. J Pediatr Psychol (2010) 0.90
Outreach, mental health, and case management services: can they help to retain HIV-positive and at-risk youth and young adults in care? Matern Child Health J (2003) 0.90
Implications of reassigning patients for the medical home: a case study. Ann Fam Med (2010) 0.88
Warfarin therapy in the HIV medical home model: low rates of therapeutic anticoagulation despite adherence and differences in dosing based on specific antiretrovirals. AIDS Patient Care STDS (2012) 0.87
More than ancillary: HIV social services, intermediate outcomes and quality of life. AIDS Care (2009) 0.83
Adolescents, health services, and access to care. J Adolesc Health (2000) 0.78
Special Projects of National Significance Program: ten models of adolescent HIV care. J Adolesc Health (1998) 0.77
Prescribing for children. Int Emerg Nurs (2011) 0.76
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med (2009) 19.90
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science (2010) 9.61
The lifetime cost of current human immunodeficiency virus care in the United States. Med Care (2006) 5.87
Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study. J Allergy Clin Immunol (2003) 5.43
Racial and gender disparities in receipt of highly active antiretroviral therapy persist in a multistate sample of HIV patients in 2001. J Acquir Immune Defic Syndr (2005) 3.92
Identification of a candidate therapeutic autophagy-inducing peptide. Nature (2013) 3.76
Late presentation for human immunodeficiency virus care in the United States and Canada. Clin Infect Dis (2010) 3.72
Cohort profile: the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD). Int J Epidemiol (2007) 3.46
Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic. AIDS (2002) 3.45
Racial and sex disparities in life expectancy losses among HIV-infected persons in the united states: impact of risk behavior, late initiation, and early discontinuation of antiretroviral therapy. Clin Infect Dis (2009) 3.30
Hospital and outpatient health services utilization among HIV-infected adults in care 2000-2002. Med Care (2005) 3.19
Illicit drug use and HIV-1 disease progression: a longitudinal study in the era of highly active antiretroviral therapy. Am J Epidemiol (2006) 2.81
Invasive cervical cancer risk among HIV-infected women: a North American multicohort collaboration prospective study. J Acquir Immune Defic Syndr (2013) 2.78
Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America. Clin Infect Dis (2012) 2.50
Human bocavirus: prevalence and clinical spectrum at a children's hospital. Clin Infect Dis (2006) 2.38
Progression to neuropsychological impairment in human immunodeficiency virus infection predicted by elevated cerebrospinal fluid levels of human immunodeficiency virus RNA. Arch Neurol (2002) 2.28
Antiretroviral medication errors remain high but are quickly corrected among hospitalized HIV-infected adults. Clin Infect Dis (2012) 2.24
Establishment, retention, and loss to follow-up in outpatient HIV care. J Acquir Immune Defic Syndr (2012) 2.19
U.S. trends in antiretroviral therapy use, HIV RNA plasma viral loads, and CD4 T-lymphocyte cell counts among HIV-infected persons, 2000 to 2008. Ann Intern Med (2012) 2.18
Incidence and outcomes of malignancy in the HAART era in an urban cohort of HIV-infected individuals. AIDS (2008) 2.14
Trends in multidrug treatment failure and subsequent mortality among antiretroviral therapy-experienced patients with HIV infection in North America. Clin Infect Dis (2009) 2.05
Long-term effects of protease-inhibitor-based combination therapy on CD4 T-cell recovery in HIV-1-infected children and adolescents. Lancet (2003) 2.04
Effect of risk-reduction counseling with rapid HIV testing on risk of acquiring sexually transmitted infections: the AWARE randomized clinical trial. JAMA (2013) 2.00
Virologic and immunologic outcomes after 24 weeks in HIV type 1-infected adolescents receiving highly active antiretroviral therapy. J Infect Dis (2004) 1.98
Comparing different measures of retention in outpatient HIV care. AIDS (2012) 1.98
HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: results from a multisite study. J Acquir Immune Defic Syndr (2011) 1.97
Early archiving and predominance of nonnucleoside reverse transcriptase inhibitor-resistant HIV-1 among recently infected infants born in the United States. J Infect Dis (2007) 1.96
Lumbar puncture in HIV-infected patients with syphilis and no neurologic symptoms. Clin Infect Dis (2009) 1.95
Trends and disparities in antiretroviral therapy initiation and virologic suppression among newly treatment-eligible HIV-infected individuals in North America, 2001-2009. Clin Infect Dis (2013) 1.94
HIV-associated distal sensory polyneuropathy in the era of highly active antiretroviral therapy: the Manhattan HIV Brain Bank. Arch Neurol (2004) 1.91
An improvement in virologic response to highly active antiretroviral therapy in clinical practice from 1996 through 2002. J Acquir Immune Defic Syndr (2005) 1.89
Long-term observation of adolescents initiating HAART therapy: three-year follow-up. AIDS Res Hum Retroviruses (2007) 1.84
Perinatal HIV counseling and rapid testing in Tijuana, Baja California, Mexico: seroprevalence and correlates of HIV infection. J Acquir Immune Defic Syndr (2006) 1.83
Implementing rapid HIV testing with or without risk-reduction counseling in drug treatment centers: results of a randomized trial. Am J Public Health (2012) 1.82
HIV risk reduction with buprenorphine-naloxone or methadone: findings from a randomized trial. J Acquir Immune Defic Syndr (2014) 1.79
Intravenous zanamivir for oseltamivir-resistant 2009 H1N1 influenza. N Engl J Med (2009) 1.79
Screening for HIV: a review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med (2005) 1.78
Retention among North American HIV-infected persons in clinical care, 2000-2008. J Acquir Immune Defic Syndr (2013) 1.73
Predictive accuracy of the Veterans Aging Cohort Study index for mortality with HIV infection: a North American cross cohort analysis. J Acquir Immune Defic Syndr (2013) 1.72
Vitamin D inhibits human immunodeficiency virus type 1 and Mycobacterium tuberculosis infection in macrophages through the induction of autophagy. PLoS Pathog (2012) 1.69
The economic burden of late entry into medical care for patients with HIV infection. Med Care (2010) 1.69
Structures of care in the clinics of the HIV Research Network. AIDS Patient Care STDS (2008) 1.69
Mortality & clinical characteristics of hospitalized adult patients with HIV in Pune, India. Indian J Med Res (2007) 1.68
Human immunodeficiency virus type-1 infection inhibits autophagy. AIDS (2008) 1.65
Antiretroviral treatment strategies in highly treatment experienced perinatally HIV-infected youth. Pediatr Infect Dis J (2012) 1.62
The lifetime medical cost savings from preventing HIV in the United States. Med Care (2015) 1.61
Patient-provider communication differs for black compared to white HIV-infected patients. AIDS Behav (2011) 1.56
Antiretroviral treatment of US children with perinatally acquired HIV infection: temporal changes in therapy between 1991 and 2009 and predictors of immunologic and virologic outcomes. J Acquir Immune Defic Syndr (2011) 1.55
CYP2B6 genetic variants are associated with nevirapine pharmacokinetics and clinical response in HIV-1-infected children. AIDS (2007) 1.53
Neurosyphilis in a clinical cohort of HIV-1-infected patients. AIDS (2008) 1.52
PG4KDS: a model for the clinical implementation of pre-emptive pharmacogenetics. Am J Med Genet C Semin Med Genet (2014) 1.49
Sustained viral suppression in HIV-infected patients receiving antiretroviral therapy. JAMA (2012) 1.48
Hormonally active vitamin D3 (1alpha,25-dihydroxycholecalciferol) triggers autophagy in human macrophages that inhibits HIV-1 infection. J Biol Chem (2011) 1.48
Clinical outcomes after an unstructured treatment interruption in children and adolescents with perinatally acquired HIV infection. Pediatrics (2008) 1.47
Differences in patient-provider communication for Hispanic compared to non-Hispanic white patients in HIV care. J Gen Intern Med (2010) 1.43
Impact of HIV severity on cognitive and adaptive functioning during childhood and adolescence. Pediatr Infect Dis J (2012) 1.41
Acute renal failure in patients with AIDS on tenofovir while receiving prolonged vancomycin course for osteomyelitis. AIDS Read (2009) 1.40
Inpatient health services utilization among HIV-infected adult patients in care 2002-2007. J Acquir Immune Defic Syndr (2010) 1.39
Provision of general and HIV-specific health maintenance in middle aged and older patients in an urban HIV clinic. AIDS Patient Care STDS (2006) 1.37
Decrease in hospitalization and mortality rates among children with perinatally acquired HIV type 1 infection receiving highly active antiretroviral therapy. Clin Infect Dis (2004) 1.37
Trends in reasons for hospitalization in a multisite United States cohort of persons living with HIV, 2001-2008. J Acquir Immune Defic Syndr (2012) 1.37
HIV prevalence during pregnancy in Tijuana, Baja California, Mexico. AIDS (2003) 1.36
Virologic and immunologic response to HAART, by age and regimen class. AIDS (2010) 1.34
Effect of age and HAART regimen on clinical response in an urban cohort of HIV-infected individuals. AIDS (2008) 1.34
Efavirenz pharmacokinetics in HIV-1-infected children are associated with CYP2B6-G516T polymorphism. J Acquir Immune Defic Syndr (2007) 1.32
HIV infection and older Americans: the public health perspective. Am J Public Health (2012) 1.31
Disparities in receipt of antiretroviral therapy among HIV-infected adults (2002-2008). Med Care (2012) 1.28
Substance use in HIV-Infected women during pregnancy: self-report versus meconium analysis. AIDS Behav (2010) 1.26
Patterns of diagnoses in hospital admissions in a multistate cohort of HIV-positive adults in 2001. Med Care (2005) 1.22
Prenatal screening for HIV: A review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med (2005) 1.21
The use of cell phone support for non-adherent HIV-infected youth and young adults: an initial randomized and controlled intervention trial. AIDS Behav (2014) 1.21
Etiology and clinical course of febrile neutropenia in children with cancer. J Pediatr Hematol Oncol (2009) 1.20
Does the presence of a current psychiatric disorder in AIDS patients affect the initiation of antiretroviral treatment and duration of therapy? J Acquir Immune Defic Syndr (2004) 1.19
Retention in care is more strongly associated with viral suppression in HIV-infected patients with lower versus higher CD4 counts. J Acquir Immune Defic Syndr (2014) 1.19
Myelomeningocele in an infant with intrauterine exposure to efavirenz. J Perinatol (2005) 1.18
Intrapatient variability of efavirenz concentrations as a predictor of virologic response to antiretroviral therapy. Antimicrob Agents Chemother (2004) 1.18
Motivating factors for high rates of influenza vaccination among healthcare workers. Vaccine (2011) 1.18
Health-related quality of life in HIV-infected patients: the role of substance use. AIDS Patient Care STDS (2008) 1.17
Primary care provider cultural competence and racial disparities in HIV care and outcomes. J Gen Intern Med (2013) 1.17
Impact of age on retention in care and viral suppression. J Acquir Immune Defic Syndr (2015) 1.17
Prevalence of primary HIV-1 drug resistance among recently infected adolescents: a multicenter adolescent medicine trials network for HIV/AIDS interventions study. J Infect Dis (2006) 1.16
Sustained savings from a longitudinal cost analysis of an internet-based preapproval antimicrobial stewardship program. Infect Control Hosp Epidemiol (2013) 1.15
HAART receipt and viral suppression among HIV-infected patients with co-occurring mental illness and illicit drug use. AIDS Care (2009) 1.14
Treatment of chronic hepatitis C: a systematic review. Hepatology (2002) 1.14